Bert O'Neil, MD

Dr. Bert H. O'Neil, MD, is a medical oncologist specializing in gastrointestinal cancers, with particular expertise in pancreatic cancer, colorectal cancer, familial colorectal cancer, and hepatocellular carcinoma. He treats advanced, unresectable colorectal cancer using genotype-guided therapies such as FOLFIRI plus bevacizumab, and focuses on precision oncology approaches that target specific molecular markers on tumors for individualized treatment. His clinical practice emphasizes therapeutic